Home LiteratureArticle Details
PMID: 4034175 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mapping X-linked ophthalmic diseases. Provisional assignment of the locus for choroideremia to Xq13-q24.

Ophthalmology ·Vol. 92 ·No. 6 ·1985-06-00 ·Pages 800-6

Lewis RA, Nussbaum RL, Ferrell R

Abstract

Choroideremia (McK 30310), an X-linked hereditary retinal dystrophy, causes nyctalopia, progressive visual field loss, and ultimately central blindness in affected males in early adulthood. We have used restriction fragment length polymorphisms from the X-chromosome to localize the region of the mutation for choroideremia in three families with this disorder. One polymorphic marker, DXYS1, located within Xq13-q21, shows no recombination with choroideremia at a LOD score of 5.78. Thus choroideremia maps within 9 centiMorgans of DXYS1 at 90% probability. Another marker, DXS11, located at Xq24-q26, shows no recombination with choroideremia but at a smaller LOD score of 1.54. These results suggest that the locus for choroideremia is distal to DXYS1 and between the two markers in the region Xq13-q24. This information may be useful for antenatal diagnosis, isolation of the mutant gene, and development of a rational therapy for the disorder.

MeSH Terms
Adult Choroid Chromosome Mapping DNA/analysis,genetics Genetic Linkage Humans Male Pedigree Polymorphism, Genetic Retinal Degeneration/genetics Uveal Diseases/genetics X Chromosome
Chemicals
DNA
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lewis R A
Nussbaum R L
Ferrell R
Article Info
Journal
Ophthalmology
Abbr.
Ophthalmology
ISSN
0161-6420
Published
1985-06-00
Pages
800-6
Language
English
Region
United States
NLM ID
7802443
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com